With the emergence of the novel surgical technique known as Natural Orifice Transluminal Endoscopic Surgery (NOTESTM), physicians and researchers are discovering new and minimally-invasive ways to conduct abdominal operations.
Scientists have identified yet another risk from a high-salt diet. High concentrations of salt in the stomach appear to induce gene activity in the ulcer-causing bacterium Helicobacter pylori, making it more virulent and increasing the likelihood of an infected person developing a severe gastric disease.
GlaxoSmithKline [NYSE:GSK] issued the following response to an article in the New England Journal of Medicine (NEJM) on Avandia? (rosiglitazone maleate), a widely used and highly effective treatment for type 2 diabetes:
Any cardio protective effect of hormone replacement therapy may be inhibited if women are taking a particular type of non-steroidal anti-inflammatory pain killer, report researchers led by Garret FitzGerald from University of Pennsylvania in a paper published this week in PLoS Medicine.
Inflammatory bowel disease, or IBD, is an umbrella term referring to a group of disorders that cause inflammation of the intestines, including ulcerative colitis, diverticular disease and perianal fistula.
Diverticulosis is a common disease of the large intestine characterized by pouches in the colon that bulge outward through weak spots in the colon musculature.
NewYork-Presbyterian Hospital/Weill Cornell Medical Center urologists are presenting exciting new research at the 2007 American Urological Association (AUA) Conference in Anaheim, May 19?May 24. Among the most significant presentations are the following:
Human fatty tissue has been shown to be a viable, pluripotent source for stem cells that can be differentiated into a variety of cell lineages, including bone, muscle and neural cell types.
The U.S. Food and Drug Administration (FDA) is aware of a potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes.
The Rhode Island Department of Health (HEALTH) reported on May 17, 2007, that the Food and Drug Administration notified the Department of Environmental Management that a sample of oysters collected from Bridgeport Seafood was positive for norovirus and other evidence of sewage contamination.